{"product_id":"continuing-education-company-28th-annual-hypertension-diabetes-dyslipidemia-conference-2024","title":"Continuing Education Company 28th Annual Hypertension, Diabetes, \u0026 Dyslipidemia Conference 2024","description":"\u003cdiv class=\"group-header field-group-div clearfix\"\u003e\r\n\u003cdiv class=\"group-header-inner field-group-div\"\u003e\r\n\u003cdiv class=\"group-course-header-right field-group-div\"\u003e\r\n\u003cdiv class=\"field field-name-title field-type-ds field-label-hidden\"\u003e\r\n\u003cdiv class=\"field-items\"\u003e\r\n\u003cdiv class=\"field-item even\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"featured__product__tab__content__item__header\"\u003e\r\n\u003cdiv class=\"fusion-layout-column fusion_builder_column fusion-builder-column-6 fusion_builder_column_3_5 3_5 fusion-flex-column\"\u003e\r\n\u003cdiv class=\"fusion-column-wrapper fusion-column-has-shadow fusion-flex-justify-content-flex-start fusion-content-layout-column\"\u003e\r\n\u003cdiv class=\"fusion-text fusion-text-2\"\u003e\r\n\u003cdiv class=\"cme-gallery\"\u003e\r\n\u003cdiv class=\"container\" data-testid=\"cme-gallery\"\u003e\r\n\u003cdiv class=\"grid col-span-full mt-3 lg:mt-0\"\u003e\r\n\u003cdiv class=\"cme-gallery__description has-rich-text col-span-full lg:col-span-9 type-body has-rich-text\"\u003e\r\n\u003ch3 class=\"product_title entry-title\"\u003eContinuing Education Company 28th Annual Hypertension, Diabetes, \u0026amp; Dyslipidemia Conference 2024\u003c\/h3\u003e\r\n\u003cstrong\u003e+ Include: 3 videos + 3 file sub vtt + 1 pdf, size: 49.1 GB\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Target Audience: cardiologists, endocrinologists, primary care physicians\u003c\/strong\u003e\r\n\r\n\u003cstrong\u003e+ Information:\u003c\/strong\u003e\r\n\u003cp data-path-to-node=\"1\"\u003eThe Continuing Education Company 28th Annual Hypertension, Diabetes, \u0026amp; Dyslipidemia Conference 2024 offers a comprehensive clinical update on the prevention, diagnosis, and management of these three interrelated metabolic and cardiovascular risk factors. The program emphasizes evidence-based strategies, updated treatment guidelines, and multidisciplinary approaches to reduce cardiovascular morbidity and optimize long-term patient outcomes in primary care.\u003c\/p\u003e\r\n\u003cp data-path-to-node=\"1\"\u003e\u003cb data-path-to-node=\"1\" data-index-in-node=\"460\"\u003eCourse Date:\u003c\/b\u003e \u003cstrong\u003eCharleston, SC, from June 19-21, 2024\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cdiv class=\"rich-content text-sm md:text-base mt-4\"\u003e\r\n\r\nExplore the flavors, sights, sounds and traditions that define \u003cstrong\u003eCharleston’s heart and soul at the 28th Annual Hypertension, Diabetes, \u0026amp; Dyslipidemia Conference\u003c\/strong\u003e, set against the backdrop of enchanting \u003cstrong\u003eCharleston, SC, from June 19-21, 2024.\u003c\/strong\u003e Join fellow healthcare professionals at the Charleston Gaillard Center for a transformative, surrounded by the city’s historic charm, vibrant culture, and unmatched southern hospitality.\r\n\r\n\u003c\/div\u003e\r\n\u003ch2 data-path-to-node=\"2\"\u003e2. Learning Objectives\u003c\/h2\u003e\r\nAs a result of this educational activity, participants should be better able to:\r\n\u003cul\u003e\r\n \t\u003cli\u003eFormulate an efficient and effective assessment and monitoring plan of a patient’s condition as it relates to hypertension, diabetes, and dyslipidemia.\u003c\/li\u003e\r\n \t\u003cli\u003eUtilize current guidelines in the diagnosis and management of diabetes, hypertension, and dyslipidemia.\u003c\/li\u003e\r\n \t\u003cli\u003eDevelop individualized interventions and treatment strategies for patients presenting with hypertension, diabetes, and\/or dyslipidemia that will translate into improved long-term outcomes.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003ch2 data-path-to-node=\"4\"\u003e3. Target Audience\u003c\/h2\u003e\r\n\u003cp data-path-to-node=\"5,0\"\u003eBest for primary care providers who want updates on managing hypertension, diabetes, and dyslipidemia.\u003c\/p\u003e\r\nThis conference is designed for physicians, nurse practitioners, physician assistants, and other related health care professionals specializing in areas of geriatric medicine, endocrinology, lipidology and\/or hypertension along with those managing patients with hypertension, diabetes, and\/or hyperlipidemia.\r\n\u003ch2 data-path-to-node=\"6\"\u003e4. Topics\u003c\/h2\u003e\r\n*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below\r\n\u003cul\u003e\r\n \t\u003cli\u003eDay 1 – June 19, 2024\u003c\/li\u003e\r\n \t\u003cli\u003eDay 2 – June 20, 2024\u003c\/li\u003e\r\n \t\u003cli\u003eDay 3 – June 21, 2024\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cstrong\u003e+ Topics:\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eWEDNESDAY, June 19, 2024 Day 1: Focus on Diabetes\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e7:50 am – 8:00 am Welcome W. Ejnes, CHCP\u003c\/li\u003e\r\n \t\u003cli\u003e8:00 am – 8:45 am Effect of Glucose-lowering Drugs on Cardiovascular Events in People with T2DM – Evidence from RCTs H. Gerstein, MD\u003c\/li\u003e\r\n \t\u003cli\u003e8:45 am – 9:30 am Standards of Care: The Non-Glycemic Targets for Cardio-Metabolic Improvement Contrasting the ADA, AACE, AHA, and EASD\/ESC T. Garvey, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:30 am – 10:15 am Growing Benefits \u0026amp; Promise of GLP-1 RA, GIP-GLP-1 Co-agonists \u0026amp; Related Drugs on Vascular Outcomes in T2DM – Evidence from RCTs H. Gerstein, MD\u003c\/li\u003e\r\n \t\u003cli\u003e10:15 am BREAK\u003c\/li\u003e\r\n \t\u003cli\u003e10:30 am – 11:15 am Obesity as a Chronic Disease: Current and Future Approaches T. Garvey, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:15 am – 11:30 am Questions for the Faculty H. Gerstein, MD \u0026amp; T. Garvey, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:30 am – 12:45 pm Cases in Diabetes and Cardiometabolic Disease H. Gerstein, MD \u0026amp; T. Garvey, MD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eTHURSDAY, June 20, 2024 Day 2: Focus on Hypertension\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e7:40 am – 7:45 am Welcome W. Ejnes, CHCP\u003c\/li\u003e\r\n \t\u003cli\u003e7:45 am – 8:00 am Day One Review of Key Points J. Basile, MD\u003c\/li\u003e\r\n \t\u003cli\u003e8:00 am – 9:00 am What’s New in Resistant Hypertension J. Basile, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:00 am – 9:45 am Primary Aldosteronism: Tips for the Clinician W. Young, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:45 am – 10:30 am An Evidence-Based Approach for Treatment of CKD in People With and Without Diabetes M. Weir, MD\u003c\/li\u003e\r\n \t\u003cli\u003e10:30 am BREAK\u003c\/li\u003e\r\n \t\u003cli\u003e10:45 am – 11:30 am Update on Pheochromocytma and Adrenal Incidentaloma W. Young, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:30 am – 12:15 pm New Approaches to Reducing Mineralocorticoid Receptor Activity; Will Outcomes Justify Cost M. Weir, MD\u003c\/li\u003e\r\n \t\u003cli\u003e12:15 pm – 12:30 pm Questions for the Faculty J. Basile, MD, W. Young, MD, \u0026amp; M. Weir, MD\u003c\/li\u003e\r\n \t\u003cli\u003e12:30 pm LUNCH BREAK (Working Lunch)\u003c\/li\u003e\r\n \t\u003cli\u003e12:45 pm – 2:15 pm Hypertension Cases J. Cohen, MD \u0026amp; Faculty Panel\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n \t\u003cli\u003e\n\u003cstrong\u003eFRIDAY, June 21, 2024 Day 3: Focus on Dyslipidemia\u003c\/strong\u003e\r\n\u003cul\u003e\r\n \t\u003cli\u003e7:40 am – 7:45 am Welcome W. Ejnes, CHCP\u003c\/li\u003e\r\n \t\u003cli\u003e7:45 am – 8:00 am Day Two Review of Key Points J. Basile, MD\u003c\/li\u003e\r\n \t\u003cli\u003e8:00 am – 8:45 am Update on LDL-C Management: Lower Targets and New Tools to Get There P. Taub, MD\u003c\/li\u003e\r\n \t\u003cli\u003e8:45 am – 9:30 am Lipoprotein (a): Current and Emerging Therapies to Decrease Cardiovascular Risk E. Michos, MD\u003c\/li\u003e\r\n \t\u003cli\u003e9:30 am – 10:15 am New Understanding in the Management of Triglycerides and HDL-Cholesterol P. Taub, MD\u003c\/li\u003e\r\n \t\u003cli\u003e10:15 am BREAK\u003c\/li\u003e\r\n \t\u003cli\u003e10:30 am – 11:15 am Lipids in Women Across the Lifespan E. Michos, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:15 am – 11:30 am Questions for the Faculty P. Taub, MD \u0026amp; E.Michos, MD\u003c\/li\u003e\r\n \t\u003cli\u003e11:30 am – 12:45 pm Lipid Cases P. Taub, MD \u0026amp; E.Michos, MD\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Medical Amboss","offers":[{"title":"Default Title","offer_id":42983529381986,"sku":"MED-AMB09241","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ContinuingEducationCompany28thAnnualHypertension_Diabetes_DyslipidemiaConference2024.jpg?v=1783797889","url":"https:\/\/meducourse.com\/products\/continuing-education-company-28th-annual-hypertension-diabetes-dyslipidemia-conference-2024","provider":"Meducourse","version":"1.0","type":"link"}